Back to companies

The United Laboratories International Holdings Ltd: Overview

The United Laboratories International Holdings Ltd (United Lab) is a pharmaceutical company that manufactures and sells pharmaceutical products. The company offers products through divisions such as preparation products, intermediate products, capsule products, raw material products, and health products. It also provides antibiotics, pharmaceutical raw materials and intermediates, material products and healthcare products. Its intermediates include amino-cephalosporanic acid, amino-penicillin acid, and octylammonium clavulanate. United Laboratories' drug products include amoxicillin capsules, ampicillin capsules, clavulana capsules, levofloxacin hydrochlorid, and cefuroxime axetil tablets, among others. It sells its products through a network of distributors in Europe, North America, East Africa and southeast Asia. United Lab is headquartered in Hong Kong.

Gain a 360-degree view of The United Laboratories International Holdings Ltd and make more informed decisions for your business Gain a 360-degree view of The United Laboratories International Holdings Ltd and make more informed decisions for your business Contact Us
Headquarters Hong Kong

Address 6 Fuk Wang Street, Yuen Long Industrial Estate


Telephone 852 26871033

No of Employees 14,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 3933 (HKG)

Revenue (2022) $1.7B 21.2% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 70.9% (2022 vs 2021)

Market Cap* $2.2B

Net Profit Margin (2022) XYZ 40.9% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

The United Laboratories International Holdings Ltd premium industry data and analytics

30+

Pipeline Drugs

Identify which of The United Laboratories International Holdings Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

30+

Clinical Trials

Determine The United Laboratories International Holdings Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Marketed Drugs

Understand The United Laboratories International Holdings Ltd’s commercialized product portfolio to stay one step ahead of the market.

10+

Catalyst Calendar

Proactively evaluate The United Laboratories International Holdings Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

8

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for The United Laboratories International Holdings Ltd’s relevant decision makers and contact details.

5

Sales & Consensus Forecasts

Understand the current and future drug revenue for The United Laboratories International Holdings Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on The United Laboratories International Holdings Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
- - -
Antimicrobial for Injection Diabetes Care Services TUL
Anti-cold, Cough Medicine USLEN
XYZ
XYZ
XYZ
Understand The United Laboratories International Holdings Ltd portfolio and identify potential areas for collaboration Understand The United Laboratories International Holdings Ltd portfolio and identify potential areas for collaboration Contact Us
Image for loader

Competitor Comparison

Key Parameters The United Laboratories International Holdings Ltd Sinovac Biotech Ltd Tasly Pharmaceutical Group Co Ltd Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Jinyao Pharmaceutical Co Ltd
Headquarters Hong Kong China China China China
City Yuen Long Beijing Tianjin Tianjin Tianjin
State/Province - Beijing Tianjin Tianjin Tianjin
No. of Employees 14,000 3,558 9,183 4,913 2,569
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Tsoi Hoi Shan Chairman Executive Board - 45
Leung Wing Hon Vice Chairman; Chief Financial Officer; Secretary Executive Board - 61
Zhu Su Yan Vice President; Director Executive Board - 58
Choy Siu Chit Executive Director Executive Board - 50
Fang Yu Ping Director; Vice President Executive Board 2008 60
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into The United Laboratories International Holdings Ltd key executives to enhance your sales strategy Gain insight into The United Laboratories International Holdings Ltd key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward